Diabetes drug can cut obesity in non-diabetics

The diabetes drug liraglutide could be used to treat obesity in non-diabetics and could also cut the risk of prediabetes, Danish research suggests.

The latest findings come as Diabetes UK warns that seven million people in the UK could be suffering from prediabetes.

The charity has developed a position statement calling for guidance to help diagnose and manage prediabetes.

The Danish study involved 564 patients, aged 18 to 65, with a BMI of 30 to 40. They received 1.2mg, 1.8mg, 2.4mg or 3.0mg of liraglutide or placebo once daily, or 120mg of orlistat three times a day orally.

All patients were asked to follow a calorie-restricted diet during the 20-week study, and to increase physical activity.

Levels of weight loss increased the higher the dose of liraglutide, with the 3.0mg dose causing a mean weight loss of 7.2kg. This compared with a weight loss of 4.1kg with orlistat and 2.8kg with placebo.

Prevalence of prediabetes also fell between 84 and 96 per cent with liraglutide treatment.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Vaccination of care home residents against COVID-19 will start on 14 December in...

How will the COVID-19 vaccination programme get underway?

How will the COVID-19 vaccination programme get underway?

Following the MHRA's approval of Pfizer/BioNTech's COVID-19 jab the government has...

NHS must keep doctors who returned in pandemic as overseas supply dries up, says GMC

NHS must keep doctors who returned in pandemic as overseas supply dries up, says GMC

Doctors who rejoined the NHS workforce in the pandemic must be urged to stay to help...

GPs unlikely to begin COVID-19 vaccination for 'at least two weeks', says BMA

GPs unlikely to begin COVID-19 vaccination for 'at least two weeks', says BMA

GP practices are unlikely to receive stocks of COVID-19 vaccine 'for at least another...

JCVI confirms priority groups for COVID-19 vaccination

JCVI confirms priority groups for COVID-19 vaccination

The Joint Committee on Vaccination and Immunisation (JCVI) has published a final...

MHRA approves Pfizer/BioNTech jab paving way for COVID-19 vaccination to start

MHRA approves Pfizer/BioNTech jab paving way for COVID-19 vaccination to start

The MHRA has approved the Pfizer/BioNTech COVID-19 vaccine for use in the UK and...